Mounia Azzi

As Vice President, Program Development and Partnerships, Dr. Azzi is leading adMare’s project identification and scientific and commercial evaluation process, ensuring a robust and strategically diverse pipeline for the organization.

With deep experience in corporate and business development, Dr. Azzi is working closely with adMare’s Venture Partners to build their portfolios through new program creation, asset identification and investment area development. In doing so, she is playing a key role in advancing adMare’s Mission to source therapeutically and commercially promising research from leading academic and biotech partners from across Canada to create and grow companies of scale.

Most recently Dr. Azzi was the Executive Global Vice President, Corporate Development (and previously Chief Business Officer) at Nexelis. Prior to Nexelis, Dr. Azzi was Director, Scientific Affairs at the NEOMED Institute, responsible for the identification and evaluation of new opportunities to complement NEOMED’s prospecting activities. Previously, she was Director of Programs at CQDM, where she was responsible for the evaluation and management of research projects and funding programs. She was also actively involved in business development activities with industry partners. She started her career as leader of the cellular biology group at Bellus Health (formerly Neurochem Inc.), where she was involved in the development of therapeutics targeting Alzheimer’s disease and diabetes.

Dr. Azzi holds a PhD in Neuroscience from Université Pierre et Marie Curie (UPMC) in Paris.